Recent Updates
Recently added Catalysts
ZLAB

argenx announces VYVGART™ approval in Japan for the treatment of generalized myasthenia gravis – Zai Lab Limited

Key Takeaway: argenx announces VYVGART™ approval in Japan for the treatment of generalized myasthenia gravis – Zai Lab Limited

Full Press Release Details

argenx announces VYVGART™ approval in Japan for the treatment of generalized myasthenia gravis – Zai Lab Limited.
Last updated: Jan 20, 2022